Home/Filings/4/0001209191-22-038597
4//SEC Filing

YOUNG JAMES F 4

Accession 0001209191-22-038597

CIK 0001000694other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 8:50 PM ET

Size

8.1 KB

Accession

0001209191-22-038597

Insider Transaction Report

Form 4
Period: 2022-06-17
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2022-06-171,4000 total
    Common Stock (1,400 underlying)
  • Exercise/Conversion

    Common Stock

    2022-06-17+1,40063,990 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,500
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
  • [F2]The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  • [F3]One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date.

Issuer

NOVAVAX INC

CIK 0001000694

Entity typeother

Related Parties

1
  • filerCIK 0001219864

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 8:50 PM ET
Size
8.1 KB